Author of

• 11929

  +

  P2.22 - Poster Session 2 - Epidemiology, Etiology (ID 167)

  • Event: WCLC 2013
  • Type: Poster Session
  • Track: Prevention & Epidemiology
  • Presentations: 1
  • Moderators:
  • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level

  • 11941

    +

    P2.22-012 - Worse survival outcomes in patients with lung cancer from deprived areas of residence in Scotland: Why? (ID 3103)

    09:30 - 09:30  |  Author(s): C. Thomson
    • Abstract

    Background
    Lung cancer survival remains poor with only modest progress in absolute terms in recent years. Survival has been lower in the UK than many comparable European countries. There is some evidence that this survival deficit is particularly apparent early during follow-up. Within the UK, survival has been lower among deprived patients. Recent evidence suggests that this 'derivation gap' in survival also predominates early during follow-up. Although early deaths could reflect advanced disease, previous research in both Scotland and England does not support the hypothesis that deprived patients with lung cancer present with more advanced disease.

    Methods
    Using Scottish lung cancer audit records linked to cancer registrations, hospital discharge records and mortality records, the aims of this project were 1) to describe patterns of survival from lung cancer by socio-economic position 2) to explore the influence of the 'deprivation gap' in survival factors such as age, sex, tumour stage, tumour morphology, emergency presentation, performance staus and co-morbidity by modelling deprivation category-specific relative survival.

    Results
    Preliminary results confirm that survival remains lower in patients with lung cancer from deprived areas of residence. In multivariate modelling, this finding does not seem to be explained by competing causes of death or stage of disease at diagnosis. The main explanatory variables seem to be performance status and treatment.

    Conclusion
    Preliminary analysis suggests that performance status and treatment are the most important explanations for the 'deprivation gap' in survival from lung cancer in Scotland.